9月12日，创新药概念股午后震荡回升，昭衍新药走出6天3板，苑东生物涨超10%，塞力医疗触及涨停，华纳药厂、皓元医药、昂利康、华海药业涨幅靠前。消息面上，创新药临床审评审批再提速，获国家全链条支持创新药发展政策体系支持，具有明显临床价值的重点创新药品种将依申请纳入30日通道。创新药临床审评审批再提速9月12日，国家药监局发布《关于优化创新药临床试验审评审批有关事项的公告》，明确提出对符合要求的...
Source Link9月12日，创新药概念股午后震荡回升，昭衍新药走出6天3板，苑东生物涨超10%，塞力医疗触及涨停，华纳药厂、皓元医药、昂利康、华海药业涨幅靠前。消息面上，创新药临床审评审批再提速，获国家全链条支持创新药发展政策体系支持，具有明显临床价值的重点创新药品种将依申请纳入30日通道。创新药临床审评审批再提速9月12日，国家药监局发布《关于优化创新药临床试验审评审批有关事项的公告》，明确提出对符合要求的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.